Oral nicotinamide reduces actinic keratoses in phase II double-blinded randomized controlled trials

J Invest Dermatol. 2012 May;132(5):1497-500. doi: 10.1038/jid.2011.459. Epub 2012 Feb 2.
No abstract available

Publication types

  • Clinical Trial, Phase II
  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Carcinoma, Basal Cell / pathology*
  • Carcinoma, Squamous Cell / pathology*
  • Cell Transformation, Neoplastic
  • Confidence Intervals
  • Double-Blind Method
  • Female
  • Humans
  • Keratosis, Actinic / drug therapy*
  • Keratosis, Actinic / prevention & control
  • Logistic Models
  • Male
  • Medication Adherence
  • Middle Aged
  • Niacinamide / administration & dosage
  • Niacinamide / therapeutic use*
  • Odds Ratio
  • Poisson Distribution
  • Skin Neoplasms / pathology*
  • Vitamin B Complex / administration & dosage
  • Vitamin B Complex / therapeutic use*

Substances

  • Vitamin B Complex
  • Niacinamide